Akebia Therapeutics
AKBA
#9606
Rank
S$0.13 B
Marketcap
S$0.50
Share price
-8.71%
Change (1 day)
-76.08%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: S$0.13 Billion

As of November 2026 Akebia Therapeutics has a market cap of S$0.13 Billion. This makes Akebia Therapeutics the world's 9606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.13 B-75.59%
2025S$0.56 B-2.2%
2024S$0.57 B87.45%
2023S$0.30 B116.81%
2022S$0.14 B-73.38%
2021S$0.53 B-0.16%
2020S$0.53 B-48.36%
2019S$1.03 B17.4%
2018S$0.88 B-6.07%
2017S$0.94 B62.82%
2016S$0.57 B3.04%
2015S$0.56 B78.86%
2014S$0.31 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Akebia Therapeutics was reported to be:

S$0.13 Billion
by Nasdaq info icon info icon
S$0.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$839.92 B 608,185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$366.59 B 265,392.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$303.97 B 220,045.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$1.33 B 865.33%๐Ÿ‡บ๐Ÿ‡ธ USA